Angiosarcoma of the seminal vesicle: A case report of long-term survival following multimodality therapy

Kenneth Chang, Terence T. Sio, Vishal S. Chandan, Matthew J. Iott, Christopher Hallemeier

Research output: Contribution to journalArticle

1 Scopus citations


Angiosarcoma of the seminal vesicle is an extremely rare malignancy, with few published case reports in the literature. We present a case of primary angiosarcoma of the seminal vesicle in a 45-year-old male who was treated with multimodality therapy, consisting of neoadjuvant chemotherapy and chemoradia-tion followed by surgical resection and intraop-erative radiation therapy. He has been free of cancer recurrence for more than six years after completion of therapy. To our knowledge, this represents the longest reported survival of a patient with this rare tumor, and one of the few cases reported using a multimodality therapy approach.

Original languageEnglish (US)
Article number5202
Pages (from-to)7-9
Number of pages3
JournalRare Tumors
Issue number1
StatePublished - Jan 29 2014



  • Angiosarcoma
  • Chemoradiation
  • Neoadjuvant
  • Prostate
  • Seminal vesicle
  • Surgery
  • Trimodality therapy

ASJC Scopus subject areas

  • Oncology
  • Histology

Cite this